AppYea Inc
OTC:APYP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
AppYea Inc
Cash & Cash Equivalents
AppYea Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
AppYea Inc
OTC:APYP
|
Cash & Cash Equivalents
$408k
|
CAGR 3-Years
89%
|
CAGR 5-Years
110%
|
CAGR 10-Years
N/A
|
|
|
Global-E Online Ltd
NASDAQ:GLBE
|
Cash & Cash Equivalents
$245.9m
|
CAGR 3-Years
5%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
N
|
Nice Ltd
TASE:NICE
|
Cash & Cash Equivalents
$379.4m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
|
|
Cyberark Software Ltd
NASDAQ:CYBR
|
Cash & Cash Equivalents
$623.2m
|
CAGR 3-Years
22%
|
CAGR 5-Years
5%
|
CAGR 10-Years
10%
|
|
|
Check Point Software Technologies Ltd
NASDAQ:CHKP
|
Cash & Cash Equivalents
$1.8B
|
CAGR 3-Years
109%
|
CAGR 5-Years
48%
|
CAGR 10-Years
25%
|
|
|
Plus500 Ltd
LSE:PLUS
|
Cash & Cash Equivalents
$801.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
AppYea Inc
Glance View
AppYea, Inc. is a digital health company, which engages in the development of wearable monitoring solutions to treat sleep apnea and snoring. The Company’s business plan focuses on two principal devices and an App in development: DreamIT and DreamIT PRO, and SleepX PRO. DreamIT is a biofeedback snoring treatment wristband, combined with the SleepX App and this wristband uses algorithms designed by SleepX combined with sensors to monitor physiological parameters during sleep. DreamIT PRO is a wristband for the treatment of sleep apnea using biofeedback in combination with the SleepX PRO app. The algorithms of SleepX PRO, combined with the wristband sensors, monitor sleep apnea events and additional physiological parameters during sleep, and when necessary. SleepX PRO is a medical application that is used to monitor breathing patterns in sleep and identify sleep apnea episodes without direct contact with the user.
See Also
What is AppYea Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
408k
USD
Based on the financial report for Dec 31, 2025, AppYea Inc's Cash & Cash Equivalents amounts to 408k USD.
What is AppYea Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
110%
Over the last year, the Cash & Cash Equivalents growth was 416%. The average annual Cash & Cash Equivalents growth rates for AppYea Inc have been 89% over the past three years , 110% over the past five years .